Talon Biomarkers

A Biomarker Discovery Engine

health AIbiomarker discoveryimmunologytranslational research

Founded2021

Employees6

LocationWhippany, NJ

About

Talon Biomarkers is a biomarker discovery engine built to capture indicators of disease and therapy from a sea of immune cells. We're fueled by a uniquely powerful and robust technology platform that changes the old-school paradigm of how a contract-research organization works. We are your partners in science, helping with experimental and study design, data acquisition, analysis, and even interpretation of results. We have strategic partnerships with influential and cutting-edge companies in the single cell, immuno-oncology, and immunoassay spaces, coupled with the expertise and creativity to realize your study goals!

Product

Value proposition: Supports analysis of cells, plasma, and tissues across research studies and clinical trials with workflow from study design through execution and data interpretation to deliver immune analyses aligned with biological questions and downstream decisions.
Target customers: Researchers in pharma/biotech, academic labs, CROs

Founders

Dr. Pratip Chattopadhyay — Founder and CEO
Arielle Ginsberg — Co-founder and Chief Commercial Officer

Products

Biomarker discovery platformImmune profilingData analyticsConsultation and support services

Key features

Integrated immune profiling across modalitiesQuestion-driven study design and analysisContextualized, interpretable resultsScalable workflows from discovery to translational studiesDecision-ready insights tied to development strategyProprietary search tool for research-backed biomarkers

Technologies

immune profilingdata analyticsbiomarker discoverytranslational researchlongitudinal studiesclinical trials

Traction metrics

Supports analysis of cells, plasma, and tissues across studies and trialsAlignment of analyses with biological questions and downstream decisionsFrom goal to answer design methodology

News

LASE Innovation and Talon Biomarkers Launch First-of-its-Kind Service to Unlock TCell Activation Kinetics at Single-Cell Resolution - LASE Innovation · 2025-08-14T19:08:15.000Z
41 NJ-Based Startups Awarded $3M from CSIT · 2024-10-16T00:00:00.000Z
Talon Biomarkers 2026: Innovative Disease Research Initiatives | Pratip Chattopadhyay posted on the topic | LinkedIn · 2026-01-12T20:08:46.000Z
LASE Innovation Appoints Dr. Yulia Shulga as Principal Scientist... · 2024-07-24T00:00:00.000Z
LASE Innovation: Home · 2025-08-13T00:00:00.000Z
Cure Member Spotlight: Gilead Kedem, MD · 2026-01-08T00:00:00.000Z